Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

165 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The clinical significance of cognition-focused interventions for cognitively impaired older adults: a systematic review of randomized controlled trials.
Kurz AF, Leucht S, Lautenschlager NT. Kurz AF, et al. Among authors: lautenschlager nt. Int Psychogeriatr. 2011 Nov;23(9):1364-75. doi: 10.1017/S1041610211001001. Epub 2011 Jul 11. Int Psychogeriatr. 2011. PMID: 21740614 Review.
Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease.
Kurz A, Egensperger R, Haupt M, Lautenschlager N, Romero B, Graeber MB, Müller U. Kurz A, et al. Neurology. 1996 Aug;47(2):440-3. doi: 10.1212/wnl.47.2.440. Neurology. 1996. PMID: 8757017
Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline.
Riemenschneider M, Schmolke M, Lautenschlager N, Guder WG, Vanderstichele H, Vanmechelen E, Kurz A. Riemenschneider M, et al. Neurosci Lett. 2000 Apr 21;284(1-2):85-8. doi: 10.1016/s0304-3940(00)00976-9. Neurosci Lett. 2000. PMID: 10771168
Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings.
Lautenschlager NT, Riemenschneider M, Drzezga A, Kurz AF. Lautenschlager NT, et al. Dement Geriatr Cogn Disord. 2001 Nov-Dec;12(6):379-86. doi: 10.1159/000051284. Dement Geriatr Cogn Disord. 2001. PMID: 11598309
Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer's disease.
Riemenschneider M, Schmolke M, Lautenschlager N, Vanderstichele H, Vanmechelen E, Guder WG, Kurz A. Riemenschneider M, et al. Neurobiol Aging. 2002 Mar-Apr;23(2):205-11. doi: 10.1016/s0197-4580(01)00272-x. Neurobiol Aging. 2002. PMID: 11804704 Clinical Trial.
Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.
Riemenschneider M, Lautenschlager N, Wagenpfeil S, Diehl J, Drzezga A, Kurz A. Riemenschneider M, et al. Arch Neurol. 2002 Nov;59(11):1729-34. doi: 10.1001/archneur.59.11.1729. Arch Neurol. 2002. PMID: 12433260
The role of biological markers in the early and differential diagnosis of Alzheimer's disease.
Kurz A, Riemenschneider M, Drzezga A, Lautenschlager N. Kurz A, et al. J Neural Transm Suppl. 2002;(62):127-33. doi: 10.1007/978-3-7091-6139-5_13. J Neural Transm Suppl. 2002. PMID: 12456058 Review.
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A. Drzezga A, et al. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. doi: 10.1007/s00259-003-1194-1. Epub 2003 May 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 12764551 Clinical Trial.
Mild cognitive impairment: making headway by stepping backwards.
Förstl H, Lautenschlager N, Bickel H. Förstl H, et al. Seishin Shinkeigaku Zasshi. 2003;105(4):370-80. Seishin Shinkeigaku Zasshi. 2003. PMID: 12806897 Review.
[Mild cognitive disorder. Questions of definition, diagnosis, prognosis and therapy].
Kurz A, Diehl J, Riemenschneider M, Perneczky R, Lautenschlager N. Kurz A, et al. Nervenarzt. 2004 Jan;75(1):6-15. doi: 10.1007/s00115-003-1568-4. Nervenarzt. 2004. PMID: 14722656 Review. German.
165 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page